APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Famotidine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Famotidine Market Outlook and Growth Opportunities 2026

Report ID 173780960422 December 2025196 pages

Choose your research edition.

Industry ResearchFamotidine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Famotidine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Famotidine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Famotidine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Famotidine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Famotidine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Famotidine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Famotidine market include UQUIFA, Rakshit Drug, Phalanx Labs, PAT IMPEX, Jayusion, Gauri Fine Chemicals, Darou Pakhsh Pharma Chem and Chempro Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Famotidine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Famotidine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Famotidine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Famotidine market size, projected growth trends, production technologies, key applications, and end-use industries.

Famotidine Segment by Company

UQUIFA

Rakshit Drug

Phalanx Labs

PAT IMPEX

Jayusion

Gauri Fine Chemicals

Darou Pakhsh Pharma Chem

Chempro Pharma

Famotidine Segment by Type

Tablets

Injection

Famotidine Segment by Application

Hospital

Clinic

Other

Famotidine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Famotidine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Famotidine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Famotidine significant trends, drivers, influence factors in global and regions.

6. To analyze Famotidine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famotidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Famotidine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famotidine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Famotidine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Famotidine industry.

Chapter 3: Detailed analysis of Famotidine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Famotidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Famotidine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Famotidine Industry Trends Table 2. Famotidine Industry Drivers Table 3. Famotidine Industry Opportunities and Challenges Table 4. Famotidine Industry Restraints Table 5. Global Famotidine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Famotidine Revenue Share by Company (2021-2026) Table 7. Global Famotidine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Famotidine Sales Volume Share by Company (2021-2026) Table 9. Global Famotidine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Famotidine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Famotidine Key Company Manufacturing Base & Headquarters Table 12. Global Famotidine Company, Product Type & Application Table 13. Global Famotidine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Famotidine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Injection Table 19. Global Famotidine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Famotidine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Famotidine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Famotidine Sales Volume Share by Type (2021-2026) Table 23. Global Famotidine Sales Volume Share by Type (2027-2032) Table 24. Global Famotidine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Famotidine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Famotidine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Famotidine Sales Value Share by Type (2021-2026) Table 28. Global Famotidine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Famotidine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Famotidine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Famotidine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Famotidine Sales Volume Share by Application (2021-2026) Table 36. Global Famotidine Sales Volume Share by Application (2027-2032) Table 37. Global Famotidine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Famotidine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Famotidine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Famotidine Sales Value Share by Application (2021-2026) Table 41. Global Famotidine Sales Value Share by Application (2027-2032) Table 42. Global Famotidine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Famotidine Sales by Region (2021-2026) & (K Units) Table 44. Global Famotidine Sales Market Share by Region (2021-2026) Table 45. Global Famotidine Sales by Region (2027-2032) & (K Units) Table 46. Global Famotidine Sales Market Share by Region (2027-2032) Table 47. Global Famotidine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Famotidine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Famotidine Sales Value Share by Region (2021-2026) Table 50. Global Famotidine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Famotidine Sales Value Share by Region (2027-2032) Table 52. Global Famotidine Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Famotidine Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Famotidine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Famotidine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Famotidine Sales by Country (2021-2026) & (K Units) Table 57. Global Famotidine Sales Market Share by Country (2021-2026) Table 58. Global Famotidine Sales by Country (2027-2032) & (K Units) Table 59. Global Famotidine Sales Market Share by Country (2027-2032) Table 60. Global Famotidine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Famotidine Sales Value Market Share by Country (2021-2026) Table 62. Global Famotidine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Famotidine Sales Value Market Share by Country (2027-2032) Table 64. UQUIFA Company Information Table 65. UQUIFA Business Overview Table 66. UQUIFA Famotidine Sales (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. UQUIFA Famotidine Product Portfolio Table 68. UQUIFA Recent Development Table 69. Rakshit Drug Company Information Table 70. Rakshit Drug Business Overview Table 71. Rakshit Drug Famotidine Sales (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Rakshit Drug Famotidine Product Portfolio Table 73. Rakshit Drug Recent Development Table 74. Phalanx Labs Company Information Table 75. Phalanx Labs Business Overview Table 76. Phalanx Labs Famotidine Sales (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Phalanx Labs Famotidine Product Portfolio Table 78. Phalanx Labs Recent Development Table 79. PAT IMPEX Company Information Table 80. PAT IMPEX Business Overview Table 81. PAT IMPEX Famotidine Sales (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. PAT IMPEX Famotidine Product Portfolio Table 83. PAT IMPEX Recent Development Table 84. Jayusion Company Information Table 85. Jayusion Business Overview Table 86. Jayusion Famotidine Sales (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Jayusion Famotidine Product Portfolio Table 88. Jayusion Recent Development Table 89. Gauri Fine Chemicals Company Information Table 90. Gauri Fine Chemicals Business Overview Table 91. Gauri Fine Chemicals Famotidine Sales (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Gauri Fine Chemicals Famotidine Product Portfolio Table 93. Gauri Fine Chemicals Recent Development Table 94. Darou Pakhsh Pharma Chem Company Information Table 95. Darou Pakhsh Pharma Chem Business Overview Table 96. Darou Pakhsh Pharma Chem Famotidine Sales (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Darou Pakhsh Pharma Chem Famotidine Product Portfolio Table 98. Darou Pakhsh Pharma Chem Recent Development Table 99. Chempro Pharma Company Information Table 100. Chempro Pharma Business Overview Table 101. Chempro Pharma Famotidine Sales (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Chempro Pharma Famotidine Product Portfolio Table 103. Chempro Pharma Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Famotidine Distributors List Table 107. Famotidine Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Famotidine Product Image Figure 2. Global Famotidine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Famotidine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Famotidine Sales (2021-2032) & (K Units) Figure 5. Global Famotidine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Famotidine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Injection Image Figure 11. Global Famotidine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Famotidine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Famotidine Sales Volume Share by Type (2021-2032) Figure 14. Global Famotidine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Famotidine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Famotidine Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Famotidine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Famotidine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Famotidine Sales Volume Share by Application (2021-2032) Figure 23. Global Famotidine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Famotidine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Famotidine Sales Value Share by Application (2021-2032) Figure 26. Global Famotidine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Famotidine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Famotidine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Famotidine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Famotidine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Famotidine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Famotidine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Famotidine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Famotidine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Famotidine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Famotidine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Famotidine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Famotidine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Famotidine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Famotidine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Famotidine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Famotidine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Famotidine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Famotidine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injection
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • UQUIFA
  • Rakshit Drug
  • Phalanx Labs
  • PAT IMPEX
  • Jayusion
  • Gauri Fine Chemicals
  • Darou Pakhsh Pharma Chem
  • Chempro Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Famotidine Sales Value (2021-2032)
  4. 1.2.2 Global Famotidine Sales Volume (2021-2032)
  5. 1.2.3 Global Famotidine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Famotidine Market Dynamics
  1. 2.1 Famotidine Industry Trends
  2. 2.2 Famotidine Industry Drivers
  3. 2.3 Famotidine Industry Opportunities and Challenges
  4. 2.4 Famotidine Industry Restraints
3 Famotidine Market by Company
  1. 3.1 Global Famotidine Company Revenue Ranking in 2025
  2. 3.2 Global Famotidine Revenue by Company (2021-2026)
  3. 3.3 Global Famotidine Sales Volume by Company (2021-2026)
  4. 3.4 Global Famotidine Average Price by Company (2021-2026)
  5. 3.5 Global Famotidine Company Ranking (2024-2026)
  6. 3.6 Global Famotidine Company Manufacturing Base and Headquarters
  7. 3.7 Global Famotidine Company Product Type and Application
  8. 3.8 Global Famotidine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Famotidine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Famotidine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Famotidine Market by Type
  1. 4.1 Famotidine Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Injection
  4. 4.2 Global Famotidine Sales Volume by Type
  5. 4.2.1 Global Famotidine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Famotidine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Famotidine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Famotidine Sales Value by Type
  9. 4.3.1 Global Famotidine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Famotidine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Famotidine Sales Value Share by Type (2021-2032)
5 Famotidine Market by Application
  1. 5.1 Famotidine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Famotidine Sales Volume by Application
  6. 5.2.1 Global Famotidine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Famotidine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Famotidine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Famotidine Sales Value by Application
  10. 5.3.1 Global Famotidine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Famotidine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Famotidine Sales Value Share by Application (2021-2032)
6 Famotidine Regional Sales and Value Analysis
  1. 6.1 Global Famotidine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Famotidine Sales by Region (2021-2032)
  3. 6.2.1 Global Famotidine Sales by Region: 2021-2026
  4. 6.2.2 Global Famotidine Sales by Region (2027-2032)
  5. 6.3 Global Famotidine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Famotidine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Famotidine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Famotidine Sales Value by Region (2027-2032)
  9. 6.5 Global Famotidine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Famotidine Sales Value (2021-2032)
  12. 6.6.2 North America Famotidine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Famotidine Sales Value (2021-2032)
  15. 6.7.2 Europe Famotidine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Famotidine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Famotidine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Famotidine Sales Value (2021-2032)
  21. 6.9.2 South America Famotidine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Famotidine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Famotidine Sales Value Share by Country, 2025 VS 2032
7 Famotidine Country-level Sales and Value Analysis
  1. 7.1 Global Famotidine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Famotidine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Famotidine Sales by Country (2021-2032)
  4. 7.3.1 Global Famotidine Sales by Country (2021-2026)
  5. 7.3.2 Global Famotidine Sales by Country (2027-2032)
  6. 7.4 Global Famotidine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Famotidine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Famotidine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Famotidine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Famotidine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Famotidine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Famotidine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Famotidine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Famotidine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Famotidine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Famotidine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Famotidine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Famotidine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Famotidine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Famotidine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Famotidine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Famotidine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Famotidine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Famotidine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Famotidine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Famotidine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Famotidine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Famotidine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Famotidine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Famotidine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Famotidine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Famotidine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Famotidine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Famotidine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Famotidine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Famotidine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Famotidine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Famotidine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Famotidine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Famotidine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Famotidine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Famotidine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Famotidine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Famotidine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Famotidine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Famotidine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Famotidine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Famotidine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Famotidine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Famotidine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Famotidine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Famotidine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Famotidine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Famotidine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Famotidine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Famotidine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Famotidine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Famotidine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Famotidine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Famotidine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Famotidine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Famotidine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Famotidine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Famotidine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Famotidine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Famotidine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Famotidine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Famotidine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Famotidine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Famotidine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Famotidine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Famotidine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Famotidine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Famotidine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Famotidine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Famotidine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Famotidine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Famotidine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Famotidine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Famotidine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Famotidine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Famotidine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Famotidine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Famotidine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Famotidine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Famotidine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Famotidine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Famotidine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Famotidine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Famotidine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Famotidine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Famotidine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 UQUIFA
  2. 8.1.1 UQUIFA Company Information
  3. 8.1.2 UQUIFA Business Overview
  4. 8.1.3 UQUIFA Famotidine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 UQUIFA Famotidine Product Portfolio
  6. 8.1.5 UQUIFA Recent Developments
  7. 8.2 Rakshit Drug
  8. 8.2.1 Rakshit Drug Company Information
  9. 8.2.2 Rakshit Drug Business Overview
  10. 8.2.3 Rakshit Drug Famotidine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Rakshit Drug Famotidine Product Portfolio
  12. 8.2.5 Rakshit Drug Recent Developments
  13. 8.3 Phalanx Labs
  14. 8.3.1 Phalanx Labs Company Information
  15. 8.3.2 Phalanx Labs Business Overview
  16. 8.3.3 Phalanx Labs Famotidine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Phalanx Labs Famotidine Product Portfolio
  18. 8.3.5 Phalanx Labs Recent Developments
  19. 8.4 PAT IMPEX
  20. 8.4.1 PAT IMPEX Company Information
  21. 8.4.2 PAT IMPEX Business Overview
  22. 8.4.3 PAT IMPEX Famotidine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 PAT IMPEX Famotidine Product Portfolio
  24. 8.4.5 PAT IMPEX Recent Developments
  25. 8.5 Jayusion
  26. 8.5.1 Jayusion Company Information
  27. 8.5.2 Jayusion Business Overview
  28. 8.5.3 Jayusion Famotidine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jayusion Famotidine Product Portfolio
  30. 8.5.5 Jayusion Recent Developments
  31. 8.6 Gauri Fine Chemicals
  32. 8.6.1 Gauri Fine Chemicals Company Information
  33. 8.6.2 Gauri Fine Chemicals Business Overview
  34. 8.6.3 Gauri Fine Chemicals Famotidine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Gauri Fine Chemicals Famotidine Product Portfolio
  36. 8.6.5 Gauri Fine Chemicals Recent Developments
  37. 8.7 Darou Pakhsh Pharma Chem
  38. 8.7.1 Darou Pakhsh Pharma Chem Company Information
  39. 8.7.2 Darou Pakhsh Pharma Chem Business Overview
  40. 8.7.3 Darou Pakhsh Pharma Chem Famotidine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Darou Pakhsh Pharma Chem Famotidine Product Portfolio
  42. 8.7.5 Darou Pakhsh Pharma Chem Recent Developments
  43. 8.8 Chempro Pharma
  44. 8.8.1 Chempro Pharma Company Information
  45. 8.8.2 Chempro Pharma Business Overview
  46. 8.8.3 Chempro Pharma Famotidine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Chempro Pharma Famotidine Product Portfolio
  48. 8.8.5 Chempro Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Famotidine Value Chain Analysis
  2. 9.1.1 Famotidine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Famotidine Sales Mode & Process
  6. 9.2 Famotidine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Famotidine Distributors
  9. 9.2.3 Famotidine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst